News
The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...
Paul Vieira covers Canada for The Wall Street Journal, and is based in Ottawa.
The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...
Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
Amid the ongoing measles outbreak, many people might be wondering: do I need to get a measles vaccine booster?
Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...
The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including ...
The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...
US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback